In the GO-FORWARD study, GLM was shown to be effective in patients who showed lower responses or who were refractory to prior MTX therapy [9, 10]. In the present retrospective analysis, manifestation of effectiveness appeared to be delayed in the bio-switching group compared with the bio-naïve group, suggesting the necessity for longer follow-up when evaluating effectiveness in patients who switch between biological therapies. In a post-hoc

analysis of the effectiveness in relation to the reasons for switching, the effectiveness did not differ significantly according to the reason (data not shown). This suggests that patients undergoing switching will respond to this therapy, regardless of the reasons for switching. This supports findings by Smolen et al. [12] that switching from other Seliciclib anti-TNF agents to GLM was effective regardless of the reasons for switching, indicating that GLM can serve as the second anti-TNF agent when patients are switched from another TNF agent. Of the five

anti-TNF agents available, including certolizumab pegol, all have different affinities to TNF-α; therefore, switching from one anti-TNF agent to another is likely to be effective. Expression of antibodies to anti-TNF antibody agents such as infliximab, adalimumab, and certolizumab pegol monotherapy is not uncommon; however, incidences of anti-GLM selleck chemicals llc antibodies in the GO-FORWARD [9] and GO-FORTH [13] studies were remarkably low. Because GLM is prepared by the transgenic mouse technique, it is an antibody with high affinity for the antigen [19], which means that formation of unstable proteins or aggregations, which can serve as immunogens,

is unlikely. Studies of GLM (100 mg) monotherapy were conducted in Caucasian and South American countries in GO-FORWARD [9, 10] and in Japan in GO-FORTH [13] and GO-MONO [16], and showed that GLM is an appropriate biological agent for preventing the loss of effectiveness in Caucasian, South American, and Japanese populations receiving long-term RA treatment [9, 10, 13, 16]. As a result of findings from the GO-FORTH [13] and GO-MONO [16] studies, in addition to Mephenoxalone the 50-mg dose, GLM (100 mg) every 4 weeks—as monotherapy and in combination with MTX—has been approved in Japan. Further studies at this dose level in larger numbers of patients are necessary. Apart from the usual limitations relating to observational data and retrospective analyses, particularly with regard to selection and enrolment bias, a major limitation of our analysis is the small patient numbers, especially for patients receiving GLM (100 mg) monotherapy. In addition, evaluation of levels of anti-GLM antibodies and the effects of GLM on structural joint damage in this real-life setting would have been useful; however, this was not evaluated in the original study.

The polyethylene tube was connected to a syringe Copanlisib containing 4% buffered paraformaldehyde, and the lungs were inflated in situ with the fixative to normal size. After 5 minutes the lungs were removed in toto

and further fixated for at least 24 hours. Tissues were embedded in paraffin in a standardized way (horizontal cut through the hilum regions) and subsequently 7 μm thick slices were cut and stained with haematoxylin/periodic acid Schiff (PAS). The degree of inflammation and morphological changes in the lungs were evaluated blindly by microscopy by two experienced researchers and revaluated in case of discrepancy as described previously [24]. Statistics The numbers of inflammatory cells in biopesticide-exposed mice were compared to the control group by means of non-parametric analysis of variance (Kruskall-Wallis). In case of significant difference in the Kruskall-Wallis test, pair-wise comparisons between the water control group and the biopesticide-exposed animals were further analysed using the Mann-Whitney’s U-test. Statistical significant

difference was accepted at p < 0.05. Lumacaftor Results Validation of actual deposited dose after inhalation Comparing the theoretically inhaled dose of Vectobac® (3.5 × 104 CFU) and actual deposited dose (2.9 × 104 CFU) revealed that 83% of the theoretically inhaled dose was deposited. For the 10 × higher concentration, the mean theoretically inhaled dose was 5.6 × 105 CFU and actual deposited dose was 5.1 × 105 CFU, i.e. 91% was deposited.

The particle counts from APS and LHPC particle counters were stable throughout the exposure (Figure 1). Figure 1 Aerosol characteristics and validation of actual deposited dose (ADD) per mouse. Particles (counts min-1) of the Vectobac® × 10 exposure aerosol were measured by APS (n= 21) and LHPC (n = 24) for different particle sizes. The theoretically 17-DMAG (Alvespimycin) HCl inhaled dose (TID) per mouse based on CFU measurements from a GSP filter sampler were compared to the ADD per mouse (n = 5 per group) for the two different exposure concentrations. Values are means with SEM. CFU recovery from BAL fluid and from total lung homogenate Comparison of the CFU present in total lung homogenate to the CFU recovered from BAL fluid revealed that an average of 13% (range 10-20%) of the total CFU was recovered by the BAL procedure. The remaining 80-90% of the CFUs were recovered from the lung homogenate of the flushed lungs. Acute inflammatory response to biopesticide instillation A clear dose-dependent increase in number of neutrophils was apparent 24 hours post i.t. instillation of the biopesticide Vectobac®. Statistically significant increased numbers of neutrophils were seen after instillation of 2 × 105 CFU or more. Furthermore, at the 1.2 × 106 CFU Vectobac®dose a significant increased number of lymphocytes and eosinophils were seen (Figure 2). Figure 2 Cells in BAL fluid after instillation of different doses of biopesticide.

These results closely depend on the quality and geometry of the nanopores used, JNK signaling pathway inhibitor most of which focus on the small nanopores with the dimension comparable to the analyzers to achieve an optimal solution. Even so, the capture rate of proteins is low in nanopore experiments, and the electroosmotic flow against electrophoretic mobilities of proteins through silicon nitride membranes is dominant in small nanopores [9, 10, 18,

27, 33, 34]. Meanwhile, the adsorption interaction of proteins easily makes the small pore plugged [31, 32]. Therefore, to reduce these negative effects, nanopores with a larger scale are an alternative choice to analyze the varied targets. First, the arriving probability of protein in pore mouth is governed by free diffusion in bulk, which is referred to the pore geometry [9, 35]. A higher capture rate is expected for large nanopores [35]. And both electroosmotic effect and protein-pore interaction corresponding to the electric double layer along the charged inner wall

will be weakened in large nanopores; thus, more proteins will freely pass through nanopores [36, 37]. Additionally, more space in large nanopores is in favor of the surface modification to change the physical and chemical properties of pores [38, 39], which will broadly expand the utility of nanopores for biological sensing. Certainly, the signal-to-noise ratio of the blockade current will inevitably deteriorate if the pore is too large. Hence, the choice of nanopore with a suitable dimension is critical for the design Cell Cycle inhibitor of nanopore Liothyronine Sodium devices to understand the physical mechanism of molecules translocating through nanopores. Herein, bovine serum albumin (BSA), an important transport protein, is chosen to pass through a silicon nitride nanopore with a diameter of 60 nm. By applying a set of biased voltages, the protein swims through the large channel with a detectable signal-to-noise ratio of the blockage current. Comparing with small nanopores, a higher threshold voltage of 300 mV is observed

to drive the protein into the nanopore. With the voltage increasing, the current blockage events are greatly enhanced and are classified as a function of voltages. At the medium-voltage region, the amplitude of blockage current increases linearly while the dwell time decreases exponentially with the increasing voltage. Despite more free space in our large nanopore, the adsorption and desorption phenomenon of proteins has also been detected with a prolonged dwell time, but it is greatly weakened compared with small nanopore cases. With further increasing voltage, the protein is more likely to be destabilized by the applied electric forces. And a couple of proteins can pass through the nanopore simultaneously. Together, the experiments yield a new aspect of protein transport through a solid-state nanopore with a large scale.

Mol Plant Pathol 2008, 9:227–235.PubMedCrossRef 38. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M: In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856–2860.PubMedCrossRef

39. Speicher KD, Kolbas O, Harper S, Speicher DW: Systematic analysis of peptide recoveries from in-gel digestions for protein identifications in proteome studies. J Biomol Tech JBT 2000, 11:74–86. 40. Granvogl B, Plöscher M, Eichacker LA: Sample preparation by in-gel digestion for mass spectrometry-based proteomics. Anal Bioanal Chem 2007, 389:991–1002.PubMedCrossRef click here 41. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551–3567.PubMedCrossRef 42. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, Duvaud S, Flegel V, Fortier A, Gasteiger E, Grosdidier A, Hernandez C, Ioannidis V, Kuznetsov D, Liechti R, Moretti S, Mostaguir K, Redaschi N, Rossier G, Xenarios I, Stockinger H: ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 2012, 40:W597-W603.PubMedCentralPubMedCrossRef

43. Vencato M, Tian F, Alfano JR, Buell learn more CR, Cartinhour S, DeClerck GA, Guttman DS, Stavrinides J, Joardar V, Lindeberg M: Bioinformatics-enabled identification of the HrpL regulon and type III secretion system effector proteins of Pseudomonas syringae pv. phaseolicola 1448A. Mol Plant Microbe Interact 2006, 19:1193–1206.PubMedCrossRef 44. Mount PI3K inhibitor DW: Using the Basic Local Alignment Search Tool (BLAST). In Bioinformatics: Sequence and Genome Analysis . 2 nd edition. Cold Spring Har Protoc 2007, 7:pdb.top17. 45. Winsor GL, Lam DKW, Fleming L, Lo R, Whiteside MD, Yu NY, Hancock REW, Brinkman

FSL: Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 2011, 39:D596-D600.PubMedCentralPubMedCrossRef Competing interests All authors of the study (SK, ASr, DP, ASt and MU) declare that there are no competing interests (whether political, personal, religious, ideological, academic, intellectual or commercial) or any other activities influencing the work. Authors’ contributions SK generated the fusion constructs, performed the levan formation, Western blot, zymogram, RT-PCR and qRT-PCR assays; ASr determined the transcriptional start site; DP generated and analysed a fusion construct; ASt conducted the MALDI-TOF data acquisition and analysis; MU coordinated the study; SK and MU prepared and revised the manuscript draft. All authors contributed to the preparation and approval of the final manuscript.”
“Background Influenza virus infections are considered a significant public health problem given that they cause seasonal epidemics and recurring pandemics [1].

Int J Hyperthermia 2006, 22:117–134.PubMedCrossRef 21. Kobelt D, Aumann J, Fichtner I, Stein U, Schlag PM, Walther W: Activation of the CMV-IE promoter by hyperthermia in vitro and in vivo: biphasic heat induction of cytosine deaminase suicide gene expression. Mol Biotechnol 2010, 46:197–205.PubMedCrossRef 22. Pshenichkin S, Surin A, Surina E, Klauzińska

M, Grajkowska E, Luchenko V, Dolińska M, Wroblewska B, Wroblewski JT: Heat shock buy Kinase Inhibitor Library enhances CMV-IE promoter-driven metabotropic glutamate receptor expression and toxicity in transfected cells. Neuropharmacology 2011, 60:1292–1300.PubMedCrossRef 23. Geelen JL, Boom R, Klaver GP, Minnaar RP, Feltkamp MC, van Milligen FJ, Sol CJ, van der Noordaa J: Transcriptional activation of the major immediate early transcription unit of human cytomegalovirus by heat-shock, arsenite and protein synthesis inhibitors. J Gen Virol 1987, 68:2925–2931.PubMedCrossRef Competing interests All authors declared no any conflict of interest. Authors’ contribution FW: Conduct experiments, prepare manuscript HW: perform experiment, data analysis JZ: perform experiments XC: cell culture

CL: experiment design, manuscript revision QH: experiment design, final approval of manuscript. All authors read and approved the final manuscript.”
“Background “”“If you have knowledge, let others light their candles with it””" “”Winston Churchill”" “”“The key question is whether there are new opportunities and new models Sorafenib nmr for scholarly publishing that would better serve researchers and better communicate and disseminate research findings” * “” “”*Digital broadband Content: Scientific Publishing, OECD, Paris. Available from: “” http://​www.​oecd.​org/​internet/​interneteconomy/​35393145.​pdf Open access (OA) paradigm has unquestionably reshaped the traditional

system of scholarly communication by closely linking the concepts of free access to research literature and its easy diffusion and re-use Tryptophan synthase through massive exploitation of Internet and related technologies and an innovative management of copyright rules. OA journals based on an “author-pays” business model are one of the two routes of the open access paradigm, the so called “gold” route. Golden OA is complementary to “green” OA, founded on depositing accepted manuscripts in institutional or discipline-based repositories. In offering a comprehensive overview of the OA movement, including its history and achievements, Peter Suber defines OA journals as: peer-reviewed journals available online to the reader “”without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself”" [1]. Recent studies of the economic implications of access to journal articles highlight the present and future scenarios of the scholarly publication system [2–5].

Similar to the stage motion and the feed rate in the same direction scratching process, the machining process with the opposite direction is also divided into the following conditions according to the high-precision stage velocity: (1) When V stage < V tip, Figure 4a,b,c shows the schematic of the fabricated nanochannel after one, two, and three tip scanning cycles, respectively. The blue block is the fabricated region in one tip scanning cycle with a length (L C) expressed www.selleckchem.com/products/AZD0530.html by Equation 12, shown in Figure 4a. The yellow block, shown in Figure 4b, is the overlapping region of the two adjacent fabricated regions with

a larger depth. Due to the L stage smaller than the L tip, the two adjacent overlapping machined regions can also be overlapped with each other (gray region with a length (L O)), as shown in Figure 4c. As shown in Equation 13, the ratio of L tip and L stage can be expressed as an integer (N) plus a fraction (a). By considering the geometric relationship, the lengths of the N + 1 and N + 2 times overlapping machined region can be obtained

Cytoskeletal Signaling inhibitor by Equations 14 and 15, respectively. From Equations 14 and 15, the period of the ladder nanostructure is calculated to be L stage. Figure 4d shows the schematic of the cross section of the machined groove in this condition with the typical condition of N = 1. L 2 and L 3 represent the lengths of the two and three times machined regions, respectively. h 2 and h 3 are the corresponding depths. h 1 represents the depth of one-time machined region. Moreover, the real pitch in scratching (Δ) in this condition can be obtained by Equation 16: (12) (13) (14) (15) (16)   (2) When V stage > V tip, similar to the condition described in part (1), the blue block which is the MycoClean Mycoplasma Removal Kit fabricated region for one scanning cycle with a length (L C) can also be expressed by Equation 12, shown in Figure 5a. The yellow block, shown in Figure 5b, is the overlapping region of the two fabricated regions with a larger depth. Due to the V stage larger

than the V tip, the two adjacent overlapping machined regions cannot be overlapped with each other. As shown in Figure 5c, the lengths of one (L 1) and two times (L 2) overlapping machined regions can be obtained by Equations 17 and 18, respectively, and h 1 and h 2 are the corresponding depths. From Equations 17 and 18, the period of the ladder nanostructure is also calculated to be L stage. Figure 5c shows the schematic of the cross section of the machined groove in this condition. The real pitch in scratching (Δ) in this condition maintained above also can be obtained by Equation 16. (17) (18)   Figure 4 Schematic of the nanochannel scratching with V stage and V tip in the opposite direction when V stage   <  V tip. Schematic of the machining state after ( a ) one, ( b ) two, and ( c ) three AFM scanning cycles.

Examination of the restricted DNA (Figure 3B) showed that only one clone (lane 12) had the pYA4590 dimer-specific learn more 1643-bp band. The most prominent band in the other lanes was a 4245-bp band expected for pACYC184-like recombination products. Nine clones contained a mixture of pACYC184 and pYA4590 (lane 1, 3-5, 8, 9, 14-16). Interplasmid recombination products Plasmids extracted from TcR clones of χ3761(pYA4464, pYA4465) were digested with NcoI and BglII. Both pYA4464 and pYA4465 are linearized into

a DNA fragment about 4 kb. Therefore, in cells containing each or both monomeric plasmids, the digested product will be a single band. The pYA4464-pYA4465 Selleck BIBW2992 hybrid will be cut into two fragments (5510 bp and 2481 bp). All four of the TcR clones we isolated and examined showed recombination product specific bands and the 4-kb band expected when each plasmid exists separately in the cell. Four tetracycline sensitive (TcS) isolates were examined and only a single band was observed, as expected (Figure 3C). These results suggest that interplasmid recombination occurred in the TcR cells and that both dimer and individual monomers corresponding to at least one of the two starting plasmids can coexist in

the same bacterial cell. We performed a similar experiment in S. Typhi strain Ty2(pYA4464, pYA4465) and obtained

identical results (data not shown). Construction of rec deletion strains We constructed a series of strains for these studies carrying deletions in either recA, recF or recJ in S. Typhimurium UK-1, S. Typhi Ty2 and S. Paratyphi A (Table 2). We also constructed ΔrecAΔ recF and ΔrecJ Δ recF double mutants in S. Typhimurium. Deletion of recA, recF and recJ results in an increase in sensitivity to UV irradiation [36, 37]. To verify the presence of these deletions phenotypically in our strains, the UV sensitivity of the S. Typhimurium mutant strains was measured. The ΔrecF and ΔrecJ mutants showed significantly lower surviving fractions than the wild type strain after the same exposure dose (Figure 4). By contrast, after five seconds of UV exposure (16 J/m2) to 2.2 × 109 CFU of the ΔrecA62 mutant Tenofovir in vitro (χ9833), we were unable to recover any surviving cells (not shown). UV resistance similar to the wild-type strain χ3761 was restored to S. Typhimurium ΔrecA and ΔrecF mutants strains after introduction of recA plasmid (pYA5002) or either recF plasmid (pYA5005/pYA5006), respectively. Transformation of either mutant strain with vector plasmid pYA5001 did not restore UV resistance (Figure 4 and data not shown for recA mutant). Table 2 The bacterial strains used in this study Strain Genotype* [parental strain] Reference or source S.

PubMedCrossRef 13. Girard V, Mourez M: Adhesion mediated by autotransporters of Gram-negative bacteria: Selleckchem Pifithrin �� structural and functional features. Res Microbiol 2006,157(5):407–416.PubMedCrossRef 14. Desvaux M, Parham NJ, Henderson IR: The autotransporter secretion system. Res Microbiol 2004,155(2):53–60.PubMedCrossRef 15. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala’Aldeen D: Type V protein secretion pathway: the autotransporter story. Microbiology and Molecular Biology Reviews 2004,68(4):692–744.PubMedCrossRef 16. Antao EM, Ewers C, Guerlebeck D, Preisinger R, Homeier T, Li G, Wieler LH: Signature-tagged

mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesin. PLoS One 2009,4(11):e7796.PubMedCrossRef

Selleck R788 17. Li G, Feng Y, Kariyawasam S, Tivendale KA, Wannemuehler Y, Zhou F, Logue CM, Miller CL, Nolan LK: AatA is a novel autotransporter and virulence factor of avian pathogenic Escherichia coli. Infect Immun 2010,78(3):898–906.PubMedCrossRef 18. Johnson TJ, Johnson SJ, Nolan LK: Complete DNA sequence of a ColBM plasmid from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV virulence plasmids. J Bacteriol 2006,188(16):5975–5983.PubMedCrossRef 19. Dozois CM, Dho-Moulin M, Bree A, Fairbrother JM, Desautels C, Curtiss R: Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli, and localization and analysis of the genetic region. General meeting of the American Society of Microbiology: 2000; Los Angeles, CA: Abstracts of the 100th General 3-oxoacyl-(acyl-carrier-protein) reductase meeting

of the American Society of Microbiology 2000. 20. Blomfield IC, McClain MS, Eisenstein BI: Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol 1991,5(6):1439–1445.PubMedCrossRef 21. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK: Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 2005,151(Pt 6):2097–2110.PubMedCrossRef 22. Schouler C, Koffmann F, Amory C, Leroy-Setrin S, Moulin-Schouleur M: Genomic subtraction for the identification of putative new virulence factors of an avian pathogenic Escherichia coli strain of O2 serogroup. Microbiology 2004,150(Pt 9):2973–2984.PubMedCrossRef 23. Kariyawasam S, Johnson TJ, Nolan LK: Unique DNA sequences of avian pathogenic Escherichia coli isolates as determined by genomic suppression subtractive hybridization. FEMS Microbiol Lett 2006,262(2):193–200.PubMedCrossRef 24. Kariyawasam S, Scaccianoce JA, Nolan LK: Common and specific genomic sequences of avian and human extraintestinal pathogenic Escherichia coli as determined by genomic subtractive hybridization. BMC Microbiol 2007,7(1):81.PubMedCrossRef 25.

One explanation for this would be the presence of two

different tyrosyl-tRNA synthetases, one of which would be induced under stress conditions (acidic pH and extremely low tyrosine concentration). In general, there is only one aminoacyl-tRNA-synthetase for each amino acid in most bacteria, however, several exceptions are known. Indeed, two see more very similar lysyl-tRNA synthetases, lysS (constitutive) and lysU (heat inducible) have been described in Escherichia coli [29]. In gram-positives, in addition to the aforementioned case of the two tyrS of E. faecalis, there are two distinct histidyl-tRNA synthetase genes in Lactococcus lactis [30], and two tyrosyl-tRNA synthetase genes (tyrS and tyrZ) and two threonyl-tRNA synthetase genes (thrS and thrZ) in Bacillus subtilis [31, 32]. In this last case, the normally silent thrZ gene is induced during threonine starvation or by reducing the intracellular concentration of ThrS, which is the housekeeping threonyl-tRNA synthetase sufficient for normal cell growth [33]. The location of genes encoding an aminoacyl-tRNA-synthetase associated to the gene clusters involved in tyramine and histamine

biosynthesis is a general feature [9, 10, 14, 16–18, 34]. One of the reasons to study the expression of tyrS this website in E. durans is to find out whether this protein could have a role on the genetic regulation of the tyramine cluster, being activated under limiting Cytidine deaminase levels of tyrosine to prevent massive decarboxylation of this amino acid, ensuring its availability for protein synthesis. Consistent with this idea would be 1) the common location of genes encoding aminoacyl-tRNA sinthetases next to the operon of decarboxylation (BA-biosynthesis) of the corresponding aminoacid [9, 10, 14, 16–18, 34], 2) the expression of this gene only under acidic pH, which is the condition

regulating positively the biosynthesis and accumulation of tyramine [19, 35] and 3) the fact that tyrS and the genes of the tyramine biosynthesis pathway (tdcA and tyrP) require opposite conditions of tyrosine concentration for optimal expression (Figure 5) [19]. Altogether, these data raise the question whether TyrS could act as a negative regulator. However, overexpression of tyrS on multicopy plasmid during growth of the E. durans strain carrying the wild-type allele had no observable effect on the expression profile of the decarboxylating gene tdcA or on the tyramine concentration observed in the supernatant. Figure 5 Genetic organization and transcriptional profile of the TDC cluster in E. durans IPLA655. Promoters (P) and termination regions are indicated. The different mRNA are represented by wavy lines. Numbers indicate the size of the corresponding gene in base pairs (bp). Regulation of the genes by tyrosine and pH is indicated below. Acidic pH is required for optimal expression of the three genes.

CrossRef 5. Hopwood DA, Kieser T: Conjugative plasmids of Streptomyces. In Bacterial Conjugation. Edited by: Clewell DB. Plenum selleckchem Press, New York; 1993:293–311. 6. Grohmann E, Muth G, Espinosa M: Conjugative plasmid transfer in gram-positive bacteria. Microbiol Mol Biol Rev 2003, 67:277–301.PubMedCrossRef 7. Fong R, Vroom JA, Hu Z, Hutchinson CR, Huang J, Cohen

SN, Kao CM: Characterization of a large, stable, high-copy-number Streptomyces plasmid that requires stability and transfer functions for heterologous polyketide overproduction. Appl Environ Microbiol 2007, 73:1296–1307.PubMedCrossRef 8. Zhang R, Zeng A, Fang P, Qin Z: Characterization of the replication and conjugation loci of Streptomyces circular plasmids pFP11 and pFP1 and their ability to propagate in linear mode with artificially attached telomeres. Appl Environ Microbiol 2008, 74:3368–3376.PubMedCrossRef 9. Bibb MJ, Ward JM, Kieser T, Cohen SN, Hopwood DA: Excision of chromosomal SB525334 research buy DNA sequences from Streptomyces coelicolor forms a novel family of plasmids detectable in Streptomyces lividans. Mol Gen Genet 1981, 184:230–240.PubMed 10. Omer CA, Cohen SN: Plasmid formation in Streptomyces:

excision and integration of the SLP1 replicon at a specific chromosomal site. Mol Gen Genet 1984, 196:429–438.PubMedCrossRef 11. Pernodet JL, Simonet JM, Guerineau M: Plasmids in different strains of Streptomyces ambofaciens: free and integrated form of plasmid pSAM2. Mol Gen Genet 1984, 198:35–41.PubMedCrossRef 12. Khan SA: Plasmid rolling-circle replication: highlights of two decades of research. Plasmid 2005, 53:126–136.PubMedCrossRef 13. Haug I, Weissenborn A, Brolle D, Bentley S, Kieser T, Altenbuchner J: Streptomyces coelicolor A3(2) plasmid SCP2*: deductions from the complete sequence. Microbiology 2003,149(Pt 2):505–513.PubMedCrossRef 14. Pettis GS, Cohen SN: selleck chemicals Transfer of the plJ101 plasmid in Streptomyces lividans requires a cis-acting function dispensable for chromosomal gene transfer. Mol Microbiol 1994, 13:955–964.PubMedCrossRef 15. Possoz C, Ribard

C, Gagnat J, Pernodet JL, Guerineau M: The integrative element pSAM2 from Streptomyces: kinetics and mode of conjugal transfer. Mol Microbiol 2001, 42:159–166.PubMedCrossRef 16. Reuther J, Gekeler C, Tiffert Y, Wohlleben W, Muth G: Unique conjugation mechanism in mycelial streptomycetes: a DNA-binding ATPase translocates unprocessed plasmid DNA at the hyphal tip. Mol Microbiol 2006, 61:436–446.PubMedCrossRef 17. Brolle DF, Pape H, Hopwood DA, Kieser T: Analysis of the transfer region of the Streptomyces plasmid SCP2. Mol Microbiol 1993, 10:157–170.PubMedCrossRef 18. Zhong L, Cheng Q, Tian X, Zhao L, Qin Z: Characterization of the replication, transfer and plasmid/lytic phage cycle of the Streptomyces plasmid-phage pZL12. J Bacteriol 2010, 192:3747–3754.PubMedCrossRef 19. Hayakawa T, Yanaka T, Sakaguchi K, Otake N, Yonehara H: A linear plasmid-like DNA in Streptomyces sp. producing lankacidin group antibiotics.